On air · 1 of 3 networks
Ultragenyx
- ultragenyx.com
- US
- 1,576 employees
Ultragenyx’s ads on LinkedIn, Meta and Google, recorded by adsrunning. Browse the latest here for free. Sign up free to see all 48. Watch Ultragenyx with Starter to get each new one in your feed.
Watchlist with Starter · $49/mo
| Network | Status | Live ads | Nov 2025LinkedIn activity · 52 weeksOct 2026 | Checked | Next step |
|---|---|---|---|---|---|
| Running | 10 | Checked 30 Oct 2026 | See all 48 ads → | ||
| Meta | Not checked | — | |||
| None recorded | 0 | No ads found on the Google Ads Transparency Center | Checked 13 Oct 2026 | Collect them with the API → |
Ultragenyx has 10 live LinkedIn ads. We recorded no Google ads on 13 Oct 2026.
Latest ads
- LINKEDIN · CAROUSELSince 3 Aug 2026
Nur für medizinische Fachkräfte. Ultragenyx veranstaltet am 25. August (von 12:45 bis 13:45 Uhr) ein Satellitensymposium, bei dem wir anhand von Fallbeispielen die Herausforderungen und Chancen bei der Behandlung von Störungen des Abbaus langkettiger Fettsäuren (Long-Chain Fatty Acid Oxidation Disorders, LC-FAOD) und Glykogenspeicherkrankheit Typ Ia (Glycogen Storage Disease Type Ia, GSD Ia) besprechen werden. Im Anschluss findet eine Frage-und-Antwort-Runde statt. 🗓️ 25. August (12:45 bis 13:45 Uhr) 🔗 https://www.ssiem2026.org/ Besuchen Sie uns auf dem SSIEM-Jahressymposium 2026 in Helsinki, Finnland! Dieses Jahr dreht sich alles um die metabolische Medizin der nächsten Generation. #SSIEM2026 #Ultragenyx
- LINKEDIN · CAROUSELSince 27 Jul 2026
For healthcare professionals only. Ultragenyx will be running a satellite symposium at SSIEM 2026, on 25th August (12:45 – 13:45), where we will use cases to illustrate the challenges and opportunities in the management of long-chain fatty acid oxidation disorders (LC-FAOD) and Glycogen Storage Disease Type Ia (GSDIa), followed by a Q&A session open to the audience. 🗓️ 25th August 2026 (12:45 – 13:45) 🔗 https://www.ssiem2026.org/ Join us at SSIEM 2026 Annual Symposium in Helsinki, Finland! This year’s theme? Next Generation Metabolic Medicine. #SSIEM2026 #Ultragenyx
- LINKEDIN · VIDEOSince 4 May 2026
Early recognition of HoFH can alter a patient’s future – and that of their families.¹ ² Your impact starts here. 1. Tromp TR, et al. Lancet. 2022;399(10326):719-728. 2. Cuchel M, et al. Eur Heart J. 2023;44(25):2277-2291.
- LINKEDIN · VIDEOSince 4 May 2026
Homozygous FH is severe, life threatening and inherited – manifestations frequently appear across family members. Early recognition of HoFH is important for timely diagnosis and management.¹ Learn how you can make a real impact. 1. Cuchel M, et al. Eur Heart J. 2023;44(25):2277-2291.
- LINKEDIN · FOLLOWSince 17 Jan 2026
Get the latest jobs and industry news
- LINKEDIN · JOBSince 3 Jan 2025
6 of 48 adsSign up to see every Ultragenyx ad, filter by format and date, and get alerts on new ones.
See all 48 adsWatch the companies you care about.
Filter every ad by industry, country, format and network, and get alerts when a company you watch starts running new ads.